The firms plan to combine Sophia's DDM software with Multiplicom's molecular diagnostic kits, and sell the solution to European hospitals and laboratories.
BioMérieux plans to use Applied Maths' solutions to support EpiSeq, its newly launched microbial sequencing service.
This summer, BioNTech Diagnostics launched MammaTyper, a CE-IVD kit for breast cancer classification that measures the expression of four genes by RT-qPCR.
By Molika Ashford
The CDC's assay will run on ABI's 7500 Fast Dx Real-Time PCR instrument or the research use only 7500 Real-Time PCR instrument.
Several of the company's microarray-based tests have been certified in China and Europe.
DxS' TheraScreen KRAS Mutation Kit
DNAPrint, Laboratory Corporation of America, Duke University, Lab21, National Institute of Diabetes and Digestive and Kidney Diseases, National Institute of Neurological Diseases and Stroke, and more …
Lab21 gains access to a phage amplification technology that it is being used to develop rapid tests for active and drug-resistant tuberculosis.
While gene therapies may have high price tags, they could be cheaper than the cost of managing disease, according to MIT's Technology Review.
Researchers are looking for markers that indicate which cancer patients may respond to immunotherapies, the Associated Press writes.
In Nature this week: paternal age associated with de novo mutations in children, and more.
Nature News writes that researchers are still wrangling over the role of the p-value.